Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution

J Proteome Res. 2019 Nov 1;18(11):4027-4037. doi: 10.1021/acs.jproteome.9b00500. Epub 2019 Oct 14.

Abstract

Various agents, including drugs as well as nonmolecular stimuli, induce alterations in the physicochemical properties of proteins in cell lysates, living cells, and organisms. These alterations can be probed by applying a stability- and solubility-modifying factor, such as elevated temperature, to a varying degree. As a second dimension of variation, drug concentration or agent intensity/concentration can be used. Compared to standard approaches where curves are fitted to protein solubility data acquired at different temperatures and drug concentrations, Proteome Integral Solubility Alteration (PISA) assay increases the analysis throughput by 1 to 2 orders of magnitude for an unlimited number of factor variation points in such a scheme. The consumption of the compound and biological material decreases in PISA by the same factor. We envision widespread use of the PISA approach in chemical biology and drug development.

Keywords: action mechanism; chemical biology; drug development; high throughput; mass spectrometry; protein solubility; protein stability; proteomics; tandem mass tag; target deconvolution.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Algorithms
  • Antimetabolites / pharmacology
  • Cell Line, Tumor
  • Chromatography, Liquid / methods
  • Fluorouracil / pharmacology
  • High-Throughput Screening Assays / methods*
  • Humans
  • Methotrexate / pharmacology
  • Protease Inhibitors / pharmacology
  • Protein Stability / drug effects
  • Proteome / chemistry
  • Proteome / drug effects
  • Proteome / metabolism*
  • Proteomics / methods*
  • Reproducibility of Results
  • Solubility
  • Tandem Mass Spectrometry / methods
  • Temperature*

Substances

  • Antimetabolites
  • Protease Inhibitors
  • Proteome
  • Fluorouracil
  • Methotrexate